Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPX054 vs Immediate-Release Carbidopa-Levodopa in Parkinson's Disease
NCT00253084Phase 2Completed
- Sponsor
- Impax Laboratories
- Start
- Nov 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IPX054 in Parkinson's disease (PD), sponsored by Impax Laboratories. Started Nov 2005; status: completed.
02
Drugs
IPX054
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00253084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253084.